Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-10-01
1996-01-09
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514466, 514450, 514452, 549362, 549436, 549437, 549438, 549441, 549443, A61K 31335, C07D31746
Patent
active
054829712
ABSTRACT:
This invention is concerned with novel compounds of formula I: ##STR1## which are selective beta.sub.3 -adrenergic agents.
REFERENCES:
patent: 4751246 (1988-06-01), Philion
patent: 5106867 (1992-04-01), Blum et al.
Simiand et al, Antidepressant Profile in rodents of SR58611A, European Journal, 219(1992), 193-201.
Birnberg Gary H.
Epstein Joseph W.
Qing Feng L.
American Cyanamid Company
Dentz Bernard
LandOfFree
Beta.sub.3 -adrenergic agents and their use in pharmaceutical co does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Beta.sub.3 -adrenergic agents and their use in pharmaceutical co, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Beta.sub.3 -adrenergic agents and their use in pharmaceutical co will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1303435